Monthly Archives: February 2013

(French) : : bilan au pic de l’épidémie

Le 27 février, les données de la surveillance de la grippe confirmaient le franchissement du pic épidémique de la grippe saisonnière. Le site Internet permet pour la deuxième année consécutive de collecter des données sur les syndromes grippaux directement auprès de la population française.

When hypertension progresses unseen

automesure de la tension artérielle

When blood pressure is normal in the doctor’s surgery, but is high at home! This is an unknown phenomenon known as “masked hypertension”. Christophe Tzourio, Research Director of Inserm unit 708 “Neuroepidemiology” (University of Bordeaux Ségalen) studied the occurrence of masked hypertension in a population of 1500 elderly persons.

February 28th 2013

Sorry, this article is only available in French.

NanoAthero: using nanomedicine to treat cardiovascular diseases

Sixteen partners from 10 European countries got together to create the “Nanomedicine for Atherosclerosis” consortium. Its aim is to study and develop the clinical feasibility of nanomedicine for targeted diagnosis and treatment of atherosclerosis.

28 February: international rare diseases day

Rare diseases currently affect fewer than one in 2000 people. There are 8,000 such diseases in the world, and five new ones are identified every month. They are generally genetic conditions, but also include auto-immune diseases, infectious diseases, cancers, etc.
The rare diseases are also sometimes described as “orphans” due to the lack of treatment, and they affect nearly three 3 million people in France and 30 million in Europe.

André Syrota reappointed as Inserm Chairman and CEO

portrait officiel André Syrota

André Syrota has been reappointed by the French government as Chairman and CEO of the National Institute of Health and Medical Research (Inserm), on the recommendation of the Minister for Higher Education and Research, Geneviève Fioraso.

February 27th 2013

Sorry, this article is only available in French.

Treatment with HDL cholesterol to aid thrombolysis

accident vasculaire cérébral

Research performed by the Neurology Department and Stroke Reception and Treatment Unit at the Bichat Hospital (AP-HP/ Paris University Diderot) and the associated INSERM Unit 698 (Prof. Amarenco, Dr Olivier Meilhac) has highlighted the benefits of good cholesterol in reducing bleeding complications in the only treatment available for embolic stroke. The results of this experiment, performed on the rat, have just been published in Stroke .

Study of the consumption of food supplements

Very little information is currently available in France about the consumption of food supplements and the associated behavioural factors, in particular in population groups such as smokers for whom, according to researchers, the taking of certain supplements could represent an increased risk in relation to certain diseases.

February 26th 2013

Sorry, this article is only available in French.

RSS Youtube